DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 88 filers reported holding DESIGN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,598 | -61.2% | 16,355 | +3.7% | 0.00% | -100.0% |
| Q2 2023 | $99,370 | +5.3% | 15,773 | -3.5% | 0.00% | 0.0% |
| Q1 2023 | $94,357 | -42.6% | 16,353 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $164,437 | -38.9% | 16,027 | -0.4% | 0.00% | -50.0% |
| Q3 2022 | $269,000 | +21.2% | 16,086 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $222,000 | +4.2% | 15,859 | +20.1% | 0.00% | +100.0% |
| Q1 2022 | $213,000 | -29.7% | 13,202 | -6.6% | 0.00% | -50.0% |
| Q4 2021 | $303,000 | +170.5% | 14,132 | +85.4% | 0.00% | +100.0% |
| Q3 2021 | $112,000 | -25.3% | 7,623 | +1.0% | 0.00% | 0.0% |
| Q2 2021 | $150,000 | – | 7,551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 2,732,501 | $81,702,000 | 7.97% |
| Cormorant Asset Management, LP | 5,114,850 | $146,409,000 | 3.26% |
| Octagon Capital Advisors LP | 250,000 | $7,475,000 | 2.82% |
| EcoR1 Capital, LLC | 1,137,940 | $34,024,000 | 1.51% |
| RA Capital Management | 2,186,636 | $65,380,000 | 0.99% |
| Avoro Capital Advisors LLC | 1,468,318 | $39,702,000 | 0.69% |
| Vivo Capital, LLC | 530,991 | $15,877,000 | 0.56% |
| Rock Springs Capital Management LP | 327,250 | $9,785,000 | 0.21% |
| Artal Group S.A. | 400,000 | $11,960,000 | 0.21% |
| Baker Brothers Advisors | 1,436,636 | $42,955,000 | 0.19% |